171 related articles for article (PubMed ID: 37273536)
21. N-glycosylation induces the CTHRC1 protein and drives oral cancer cell migration.
Liu G; Sengupta PK; Jamal B; Yang HY; Bouchie MP; Lindner V; Varelas X; Kukuruzinska MA
J Biol Chem; 2013 Jul; 288(28):20217-27. PubMed ID: 23703614
[TBL] [Abstract][Full Text] [Related]
22. GAB1 is upregulated to promote anaplastic thyroid cancer cell migration through AKT-MDR1.
Song P; Xu H; He Y; Sun J; Xu Z; Huang P; Ge M; Zhang X; Ke Y; Cheng H
Biochem Biophys Res Commun; 2022 Jun; 607():36-43. PubMed ID: 35366541
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of collagen triple helix repeat containing 1 (CTHRC1) is associated with tumour aggressiveness and poor prognosis in human non-small cell lung cancer.
Ke Z; He W; Lai Y; Guo X; Chen S; Li S; Wang Y; Wang L
Oncotarget; 2014 Oct; 5(19):9410-24. PubMed ID: 25238260
[TBL] [Abstract][Full Text] [Related]
24. [Role of CTHRC1 in proliferation, migration and invasion of human colorectal cancer cells].
Yan L; Ye GT; Shen Z; Zhu X; Liu H; Li G
Nan Fang Yi Ke Da Xue Xue Bao; 2015 May; 35(5):767-71, 776. PubMed ID: 26018280
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of microR-147b represses the proliferation and invasion of thyroid carcinoma cells by inhibiting Wnt/β-catenin signaling via targeting SOX15.
Xu C; Liu J; Yao X; Bai Y; Zhao Q; Zhao R; Kou B; Li H; Han P; Wang X; Guo L; Zheng Z; Zhang S
Mol Cell Endocrinol; 2020 Feb; 501():110662. PubMed ID: 31760045
[TBL] [Abstract][Full Text] [Related]
26. CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9.
He W; Zhang H; Wang Y; Zhou Y; Luo Y; Cui Y; Jiang N; Jiang W; Wang H; Xu D; Li S; Wang Z; Chen Y; Sun Y; Zhang Y; Tseng HR; Zou X; Wang L; Ke Z
BMC Cancer; 2018 Apr; 18(1):400. PubMed ID: 29631554
[TBL] [Abstract][Full Text] [Related]
27. Cancer-associated fibroblast-secreted collagen triple helix repeat containing-1 promotes breast cancer cell migration, invasiveness and epithelial-mesenchymal transition by activating the Wnt/β-catenin pathway.
Li H; Liu W; Zhang X; Wang Y
Oncol Lett; 2021 Dec; 22(6):814. PubMed ID: 34671428
[TBL] [Abstract][Full Text] [Related]
28. Integrated analysis of transcriptome data revealed MMP3 and MMP13 as critical genes in anaplastic thyroid cancer progression.
Ma Y; Cang S; Li G; Su Y; Zhang H; Wang L; Yang J; Shi X; Qin G; Yuan H
J Cell Physiol; 2019 Dec; 234(12):22260-22271. PubMed ID: 31081124
[TBL] [Abstract][Full Text] [Related]
29. Genomic amplification of long noncoding RNA HOTAIRM1 drives anaplastic thyroid cancer progression via repressing miR-144 biogenesis.
Zhang L; Zhang J; Li S; Zhang Y; Liu Y; Dong J; Zhao W; Yu B; Wang H; Liu J
RNA Biol; 2021 Apr; 18(4):547-562. PubMed ID: 32951513
[TBL] [Abstract][Full Text] [Related]
30. Forkhead box F2/ Lysyl oxidase like 1 contribute to epithelial-mesenchymal transition and angiogenesis in thyroid cancer.
Fang H; Fu K; Shi P; Zhao Z; Yang F; Liu Y
Cell Signal; 2024 Jan; 113():110956. PubMed ID: 37918464
[TBL] [Abstract][Full Text] [Related]
31. IQGAP1 promotes pancreatic cancer progression and epithelial-mesenchymal transition (EMT) through Wnt/β-catenin signaling.
Hu W; Wang Z; Zhang S; Lu X; Wu J; Yu K; Ji A; Lu W; Wang Z; Wu J; Jiang C
Sci Rep; 2019 May; 9(1):7539. PubMed ID: 31101875
[TBL] [Abstract][Full Text] [Related]
32. miR30a inhibits LOX expression and anaplastic thyroid cancer progression.
Boufraqech M; Nilubol N; Zhang L; Gara SK; Sadowski SM; Mehta A; He M; Davis S; Dreiling J; Copland JA; Smallridge RC; Quezado MM; Kebebew E
Cancer Res; 2015 Jan; 75(2):367-77. PubMed ID: 25488748
[TBL] [Abstract][Full Text] [Related]
33. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
[TBL] [Abstract][Full Text] [Related]
34. CRSP8 promotes thyroid cancer progression by antagonizing IKKα-induced cell differentiation.
Liao Y; Hua Y; Li Y; Zhang C; Yu W; Guo P; Zou K; Li W; Sun Y; Wang R; Zuo Y; Sui S; Tian C; Hao J; Chen M; Hu S; Chen M; Long Q; Wang X; Zou L; Xie F; Guo W; Deng W
Cell Death Differ; 2021 Apr; 28(4):1347-1363. PubMed ID: 33162555
[TBL] [Abstract][Full Text] [Related]
35. FOXN3 suppresses the growth and invasion of papillary thyroid cancer through the inactivation of Wnt/β-catenin pathway.
Zhao C; Mo L; Li C; Han S; Zhao W; Liu L
Mol Cell Endocrinol; 2020 Sep; 515():110925. PubMed ID: 32619584
[TBL] [Abstract][Full Text] [Related]
36. OVOL2 impairs RHO GTPase signaling to restrain mitosis and aggressiveness of Anaplastic Thyroid Cancer.
Gugnoni M; Manzotti G; Vitale E; Sauta E; Torricelli F; Reggiani F; Pistoni M; Piana S; Ciarrocchi A
J Exp Clin Cancer Res; 2022 Mar; 41(1):108. PubMed ID: 35337349
[TBL] [Abstract][Full Text] [Related]
37. GANT61 suppresses cell survival, invasion and epithelial-mesenchymal transition through inactivating AKT/mTOR and JAK/STAT3 pathways in anaplastic thyroid carcinoma.
Gao H; Wang W; Li Q
Cancer Biol Ther; 2022 Dec; 23(1):369-377. PubMed ID: 35491899
[TBL] [Abstract][Full Text] [Related]
38. Let-7b inhibits cell proliferation, migration, and invasion through targeting Cthrc1 in gastric cancer.
Yu J; Feng J; Zhi X; Tang J; Li Z; Xu Y; Yang L; Hu Z; Xu Z
Tumour Biol; 2015 May; 36(5):3221-9. PubMed ID: 25510669
[TBL] [Abstract][Full Text] [Related]
39. KLF5 influences cell biological function and chemotherapy sensitivity through the JNK signaling pathway in anaplastic thyroid carcinoma.
Wang Z; Qiu X; Zhang H; Li W
J Biochem Mol Toxicol; 2020 May; 34(5):e22469. PubMed ID: 32173973
[TBL] [Abstract][Full Text] [Related]
40. MiR-200c regulates invasion, proliferation and EMT of anaplastic thyroid cancer cells by targeting parathyroid hormone like hormone.
Zhang Y; Duan Y; Wu C; Peng W; Chen W; Wang L; Deng Z
Growth Factors; 2022 Nov; 40(5-6):175-185. PubMed ID: 36067091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]